002630.KS
ORIENT BIO Inc.
KSC · Healthcare · Biotechnology · KR
KRW 913.00
+8.69%Year over year
Reported trailing growth
- Revenue
- +1.7%
- EBITDA
- —
- EBIT
- -53.5%
- EPS
- —
- Free cash flow
- +92.4%
- Operating cash flow
- -35.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.8%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025